Literature DB >> 7363938

Antinociceptive effects of baclofen and muscimol upon intraventricular administration.

J M Liebman, G Pastor.   

Abstract

The effects of intraventricularly administered baclofen and muscimol were investigated on tail-flick responding and on vocalization and motor responses to nociceptive pinch. Baclofen (1 microgram) and muscimol (0.1 microgram) strongly reduced responding to pinch, particularly vocalization, without altering tail-flick responding. When given systemically, however, baclofen markedly attenuated tail-flick as well as pinch responding. Muscimol produced only weak antinociception by systemic administration, suggesting that it may have poor access to brain. At antinociceptive doses, i. vent. muscimol produced less apparent muscle relaxation than did baclofen. These results suggest that baclofen's antinociceptive action may be mediated in part by a supraspinal, GABAergic substrate, in addition to a spinal component which may not directly involve GABA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7363938     DOI: 10.1016/0014-2999(80)90124-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice.

Authors:  Marina N Asiedu; Galo Mejia; Michael K Ossipov; T Phillip Malan; Kai Kaila; Theodore J Price
Journal:  J Pain       Date:  2012-04-25       Impact factor: 5.820

2.  Intracisternal or intrathecal glycine, taurine, or muscimol inhibit bicuculline-induced allodynia and thermal hyperalgesia in mice.

Authors:  Il-ok Lee; Eui-sung Lim
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

3.  Role of histamine in rodent antinociception.

Authors:  P Malmberg-Aiello; C Lamberti; C Ghelardini; A Giotti; A Bartolini
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

4.  GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists.

Authors:  H Teoh; M Malcangio; N G Bowery
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  CGP 35348, a new GABAB antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen.

Authors:  M Malcangio; C Ghelardini; A Giotti; P Malmberg-Aiello; A Bartolini
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

6.  Lack of effect of baclofen on substance P and somatostatin release from the spinal cord in vitro.

Authors:  J Sawynok; N Kato; V Havlicek; F S LaBella
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

7.  Periaqueductal gray matter involvement in the muscimol-induced decrease of morphine antinociception.

Authors:  F Zambotti; N Zonta; M Parenti; R Tommasi; L Vicentini; F Conci; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

8.  Theophylline-induced potentiation of the antinociceptive action of baclofen.

Authors:  J Sawynok
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

9.  Effects of some GABA-mimetic drugs on the antinociceptive activity of morphine and beta-endorphin in rats.

Authors:  N Zonta; F Zambotti; L Vicentini; R Tammiso; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

10.  The use of baclofen in cluster headache.

Authors:  R Hering-Hanit; N Gadoth
Journal:  Curr Pain Headache Rep       Date:  2001-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.